Characterization of HULC, a Novel Gene With Striking Up-Regulation in Hepatocellular Carcinoma, as Noncoding RNA

Gastroenterology

Volumn 132, Issue 1, 2007, Pages 330-342

  Panzitt, Katrin ^a   Tschernatsch, Marisa M O ^a   Guelly, Christian ^b   Moustafa, Tarek ^b   Stradner, Martin ^a   Strohmaier, Heimo M ^b   Buck, Charles R ^b   Denk, Helmut ^a   Schroeder, Renée ^c   Trauner, Michael ^d   Zatloukal, Kurt ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b ORIDIS Biomed GmbH   (Austria)

^c MAX F PERUTZ LABORATORIES   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HIGHLY UP REGULATED IN LIVER CANCER PROTEIN; PROTEIN DERIVATIVE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LIBRARY; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN TISSUE; IN SITU HYBRIDIZATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MOLECULAR CLONING; MONKEY; NODULAR HYPERPLASIA; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME; RNA SPLICING; RNA TRANSLATION; TRANSPOSON; UPREGULATION;

EID: 33846223294     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.08.026     Document Type: Article

References (41)

1. Mattick J.S. Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2 (2001) 986-991
2. Costa F.F. Non-coding RNAs: new players in eukaryotic biology. Gene 357 (2005) 83-94
3. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., Sweet-Cordero A., Ebert B.L., Mak R.H., Ferrando A.A., Downing J.R., Jacks T., Horvitz H.R., and Golub T.R. MicroRNA expression profiles classify human cancers. Nature 435 (2005) 834-838
4. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., Barzilai A., Einat P., Einav U., Meiri E., Sharon E., Spector Y., and Bentwich Z. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37 (2005) 766-770
5. Jopling C., Yi M., Lancaster A., Lemon S., and Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309 (2005) 1577-1581
6. Erdmann V.A., Szymanski M., Hochberg A., de Groot N., and Barciszewski J. Collection of mRNA-like non-coding RNAs. Nucleic Acids Res 27 (1999) 192-195
7. Tam W., Ben-Yehuda D., and Hayward W.S. Bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its non-coding RNA. Mol Cell Biol 3 (1997) 1490-1502
8. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., Thomas M., Berdel W.E., Serve H., and Muller-Tidow C. MALAT-1, a novel non-coding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22 (2003) 8031-8041
9. Chen W., Bocker W., Brosius J., and Tiedge H. Expression of neural BC200 RNA in human tumours. J Pathol 183 (1997) 345-351
10. Li J., Witte D.P., Van Dyke T., and Askew D.S. Expression of the putative proto-oncogene His-1 in normal and neoplastic tissues. Am J Pathol 150 (1997) 1297-1305
11. Srikantan V., Zou Z., Petrovics G., Xu L., Augustus M., Davis L., Livezey J.R., Connell T., Sesterhenn I.A., Yoshino K., Buzard G.S., Mostofi F.K., McLeod D.G., Moul J.W., and Srivastava S. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc Natl Acad Sci U S A 97 (2000) 12216-12221
12. Bussemakers M.J., van Bokhoven A., Verhaegh G.W., Smit F.P., Karthaus H.F., Schalken J.A., Debruyne F.M., Ru N., and Isaacs W.B. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59 (1999) 5975-5979
13. Petrovics G., Zhang W., Makarem M., Street J.P., Connelly R., Sun L., Sesterhenn I.A., Srikantan V., Moul J.W., and Srivastava S. Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients. Oncogene 23 (2004) 605-611
14. Iacoangeli A., Lin Y., Morley E.J., Muslimov I.A., Bianchi R., Reilly J., Weedon J., Diallo R., Bocker W., and Tiedge H. BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis 25 (2004) 2125-2133
15. Parkin D.M., Bray F., Ferlay J., and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153-156
16. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
17. Roskams T., De Vos R., and Desmet V. "Undifferentiated progenitor cells" in focal nodular hyperplasia of the liver. Histopathology 28 (1996) 291-299
18. Hegde P., Qi R., Abernathy K., Gay C., Dharap S., Gaspard R., Hughes J.E., Snesrud E., Lee N., and Quackenbush J. A concise guide to cDNA microarray analysis. BioTechniques 29 (2000) 548-550
19. Hrzenjak A., Moinfar F., Tavassoli F., Strohmeier B., Kremser M.-L., Zatloukal K., and Denk H. JAZF1/JJAZ1 gene fusion in endometrial stroma sarcomas. J Mol Diagn 7 (2005) 388-395
20. Fickert P., Trauner M., Fuchsbichler A., Stumptner C., Zatloukal K., and Denk H. Cytokeratins as targets for bile acid-induced toxicity. Am J Pathol 160 (2002) 491-499
21. Wang Z., and Brown D.D. A gene expression screen. Proc Natl Acad Sci U S A 88 (1991) 11505-11509
22. Christa L., Simon M.T., Flinois J.P., Gebhardt R., Brechot C., and Lasserre C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 106 (1994) 1312-1320
23. Santoni-Rugiu E., Jensen M.R., and Thorgeirsson S.S. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res 58 (1998) 123-134
24. Smit A. Identification of a new, abundant superfamily of mammalian LTR-transposons. Nucleic Acids Res 2 (1993) 1863-1872
25. Skryabin B.V., Kremerskothen J., Vassilacopoulou D., Disotell T.R., Kapitonov V.V., Jurka J., and Brosius J. The BC200 RNA gene and its neural expression are conserved in Anthropoidea (Primates). J Mol Evol 47 (1998) 677-685
26. Mattick J.S. Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 25 (2003) 930-939
27. Cui H., Onyango P., Brandenburg S., Wu Y., Hsieh C.L., and Feinberg A.P. Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res 62 (2002) 6442-6446
28. Zalfa F., Giorgi M., Primerano B., Moro A., Di Penta A., Reis S., Oostra B., and Bagni C. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112 (2003) 317-327
29. Parmar K.M., Larman B., Dai G., Zhang Y., Wang E.T., Moorthy S.N., Kratz J.R., Lin Z., Jain M.K., Gimbrone M.A., and Garcia-Cardena G. Intergration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116 (2006) 49-58
30. Chen X., Cheung S.T., So S., Fan S.T., Barry C., Higgins J., Lai K.M., Ji J., Dudoit S., Ng I.O., Van De Rijn M., Botstein D., and Brown P.O. Gene expression patterns in human liver cancers. Mol Biol Cell 13 (2002) 1929-1939
31. Ye Q.H., Qin L.X., Forgues M., He P., Kim J.W., Peng A.C., Simon R., Li Y., Robles A.I., Chen Y., Ma Z.C., Wu Z.Q., Ye S.L., Liu Y.K., Tang Z.Y., and Wang X.W. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med 9 (2003) 416-423
32. Xu X.R., Huang J., Xu Z.G., Qian B.Z., Zhu Z.D., Yan Q., Cai T., Zhang X., Xiao H.S., Qu J., Liu F., Huang Q.H., Cheng Z.H., Li N.G., Du J.J., Hu W., Shen K.T., Lu G., Fu G., Zhong M., Xu S.H., Gu W.Y., Huang W., Zhao X.T., Hu G.X., Gu J.R., Chen Z., and Han Z.G. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding non-cancerous liver. Proc Natl Acad Sci U S A 98 (2001) 15089-15094
33. Eferl R., Ricci R., Kenner L., Zenz R., David J.P., Rath M., and Wagner E.F. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112 (2003) 181-192
34. Feitelson M.A., Sun B., Satiroglu Tufan N.L., Liu J., Pan J., and Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene 21 (2002) 2593-2604
35. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., and Perret C. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 21 (2002) 8293-8301
36. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amit S., Kasem S., Gutkovich-Pyest E., Urieli-Shoval S., Galun E., and Ben-Neriah Y. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
37. Okabe H., Satoh S., Kato T., Kitahara O., Yanagawa R., Yamaoka Y., Tsunoda T., Furukawa Y., and Nakamura Y. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 61 (2001) 2129-2137
38. Brosius J. Gene duplication and other evolutionary strategies: from the RNA world to the future. J Struct Funct Genomics 3 (2003) 1-17
39. Brosius J., and Gould S.J. On "genomenclature": a comprehensive (and respectful) taxonomy for pseudogenes and other "junk DNA.". Proc Natl Acad Sci U S A 89 (1992) 10706-10710
40. Pham J.W., Pellino J.L., Lee Y.S., Carthew R.W., and Sontheimer E.J. A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila. Cell 117 (2004) 83-94
41. de Kok J.B., Verhaegh G.W., Roelofs R.W., Hessels D., Kiemeney L.A., Aalders T.W., Swinkels D.W., and Schalken J.A. DD3(PCA3), a very sensitive and specific marker to detect prostate tumors. Cancer Res 62 (2002) 2695-2698